TALOS: a multicenter, randomized, double-blind, placebo-controlled trial to test the effects of citalopram in patients with acute stroke.
Kristian Lundsgaard KraglundJanne Kaergaard MortensenErik Lerkevang GroveSøren Paaske JohnsenGrethe AndersenPublished in: International journal of stroke : official journal of the International Stroke Society (2015)
SSRI treatment is well tolerated and overall beneficial in the wake of stroke; it may also be neuroprotective and prevent new vascular events.